Authors

  • Нарзуллаева Д.У., Тошпулатова А.З.

Keywords:

нейротрофический фактор головного мозга, ганглиозные клетки сетчатки, глаукома.

References

Бузруков Б.Т. Нарзуллаева Д.У., Бобоха Л.Ю. (2022) Особенности диагностики и лечения глаукомы у детей. Узбекский медицинский журнал №5:20-25.

Нарзуллаева Д.У. (2024). Вестник Ташкентской Медицинской Академии.138(4):11–15. 138(4):11–15. (In Russ.).

Нарзуллаева Д.У., Латипова Н.Х., Бобоха Л.Ю. (2024) Значение родительского комплаенса у детей с глаукомой. Вестник офтальмологии. 138(4):11–15.

Хамроева Ю.А.,Хамраева Л.С.(2022)Оптико-биоетрические показатели глаза у детей при ювенильной глаукома, сочетанной с миопией. Российский офтальмологический журнал. №3, 75-79.

Alessio P., Giuliana M., Ruggiero F., Gabriele B., Marina F., Luca G. M., Enrico T. A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays // Sci Rep. – 2015. – Vol. 5. – Article number 17989.,

Almasieh M., Levin L. A. (2017). Neuroprotection in Glaucoma: Animal Models and Clinical Trials. Annu. Rev. Vis. Sci. 3, 91–120.

Alvarez-Buylla A., Garcia-Verdugo J.M. Neurogenesis in Adult Subventricular Zone // The Journal of Neuroscience. – 2002. – Vol. 22(3). – P. 629-634.

Aquino L. G., Aquino N. M. (2020). Evaluation of Macular Ganglion Cell Layer Thickness vs Peripapillary Retinal Nerve Fiber Layer Thickness for Glaucoma Detection Using Spectral-Domain Optical Coherence Tomography in a Tertiary Philippine Hospital. J. Curr. Glaucoma Pract. 14 (2), 50.

Ascaño M., Richmond A., Borden P., Kuruvilla R. Axonal targeting of Trk receptors via transcytosis regulates sensitivity to neurotrophin responses. J. Neurosci. 2009; 29(37):11674–11685.

Barde Y. A., Edgar D., Thoenen H. (1982). Purification of a New Neurotrophic Factor from Mammalian Brain. EMBO J. 1 (5), 549–553.

Bayer A.U., Ferrari F., Erb C. High occurrence rate of glaucoma among patients with Alzheimer`s disease // Eur. Neurol. – 2002. – Vol. 47. – P. 165-168.

Beeri M. S., Sonnen J. (2016). Brain BDNF Expression as a Biomarker for Cognitive Reserve against Alzheimer Disease Progression. Neuro-logy 86, 702-703

Bizrah M., Guo L., Cordeiro M.F. Glaucoma and Alzheimer's disease in the elderly //Aging Health. – 2011. – N 5. – Р. 719–733. Gupta N., Yucel Y.H. Glaucoma as a neurodegenerative disease // Current Opinion in Opthal. – 2007. – Vol. 18. – P. 110-114.

Borzenok S.A., Khubetsova M.Kh., Saburina I.N., Gavrilova N.A., Tonaeva Kh.D., Ostrovskiy D.S., Lanevskaya N.I., Kosheleva N.V., Zurina I.M. Cellular neuroprotection as a modern treatment approach for optic neuropathy. Russian Journal of Transplantology and Artificial Organs. 2017;19(1):63-73.

Boudewijn A.A., Indira T., Barbara F., Jacqueline G., Martin H., Buitelaar K., Richard C. Serum brain-derived neurotrophic factor: Determinants and relationship with depressive symptoms in a community population of middle aged and elderly people // World J Biol Psychiatry. – 2012. – Vol. 13. – N 1. P. 39-47.

Chen D.W., Foldvari M. In vitro bioassay model for screening non-viral neurotrophic factor gene delivery systems for glaucoma treatment // Drug Deliv Transl Res. – 2016. – Vol. 6. – N 6. – P. 676-685.

Chen J., Miao Y., Wang X.H., Wang Z. Elevation of p-NR2A (S1232) by Cdk5/p35 contributes to retinal ganglion cell apoptosis in a rat experimental glaucoma model // Eye (Lond.). – 2011. – Vol. 25, № 5. – P. 545-553.

Clark A.F. The cell and molecular biology of glaucoma: biomechanical factors in glaucoma // Investig. Ophthalm. and Vis. Scien. 2012. Vol. 53, No. 5. P. 2473–2475.

Coimbra J.P., Collin S.P., Hart N.S. Topographic specializations in the retinal ganglion cell layer of Australian passerines // J. Comp. Neurol. 2014. Vol. 522, No. 16. P. 3609–3628.

Cordeiro M.F., Migdal C., Bloom P., Fitzke F.W., Moss S.E. Imaging apoptosis in the eye Cell Death Dis // Eye (Lond.). – 2011. – Vol. 5. – P. 545-553.].

Cosker K.E., Courchesne S.L., Segal R.A. Action in the axon: generation and transport of signaling endosomes. Curr. Opin. Neurobiol. 2008; 18(3): 270–275.

De Groef L., Van Hove I., Dekeyster E. et al. MMPs in the trabecular meshwork: promising targets for future glaucoma therapies? // Invest. Ophthalmol. Vis. Sci. – 2013. – Vol. 54, № 12. – P. 7756-7763.

Domenici L., Origlia N., Falsini B., Cerri E., Barloscio D., Fabiani C., Sanso M., Giovannini L. Rescue of retinal function by BDNF in a mouse model of glaucoma // PLoS One. – 2014. – Vol. 23. – N 9. – e115579.

Enciu A.M., Nicolescu M.I., Manole C.G., Muresanu D.F., Popescu L.M., Popescu B.O. Neuroregeneration in neurodegenerative disorders // BMC Neurol. – 2011. – N 1. – P. 1-7.

Eyileten C., Sharif L., Wicik Z., Jakubik D., Jarosz-Popek J., Soplinska A., et al. (2021). The Relation of the Brain-Derived Neurotrophic Factor with microRNAs in Neurodegenerative Diseases and Ischemic Stroke. Mol. Neurobiol. 58 (1), 329–347.

Fiedorowicz E., Cieślińska A., Kuklo P., Grzybowski A. (2021). Protein Biomarkers in Glaucoma: A Review. J. Clin. Med. 10 (22), 5388.

Gupta MP, Herzlich AA, Sauer T., Chan CC (2016). Retinal Anatomy and Pathology. Dev. Ophthalmol. 55, 7–17

Gupta N., Ang L.C., Noel de Tilly L., Yucel Y.H. Human glaucoma and neuronal degeneration in the intracranial optic nerve, lateral geniculate nucleus and visual cortex of the brain // Br J Ophthalmol. – 2006. Vol. 90. – N 6. – P. 674-678.

Hare W.A., Ton H., Ruiz G., Feldmann B., Wijono M., WoldeMussie E. Characterization of retinal injury using ERG measures obtained with both conventional and multifocal methods in chronic ocular hypertensive primates // Invest Ophthalmol Vis Sci. – 2001. – Vol. 42. – N 1. – P. 127-136.

Harrell C. R., Fellabaum C., Arsenijevic A., Markovic B. S., Djonov V., Volarevic V. (2019). Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma. Stem cells Int. 2019. 10.1155/2019/7869130.

Ibáñez C. F., Andressoo J-O. (2017). Biology of GDNF and its Receptors—Relevance for Disorders of the Central Nervous System. Neurobiol. Dis. 97, 80–89.

Iwabe S., Moreno-Mendoza N.A., Trigo-Tavera F. et al. Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma // Vet. Ophthalmol. – 2007. – Vol.10. – N 1.– P.12-19.

Izzotti A., Sacca S.C., Longobardi M., Cartiglia C. Mitochondrial damage in the trabecular meshwork of patients with glaucoma // Arch. Ophthalmol. – 2010. – Vol. 128. – P. 724-730.

Kim J. H., Caprioli J. Intraocular Pressure Fluctuation: Is it Important? J. ophthalmic & Vis. Res. (2018). 13 (2), 170.

Kim, J.W. Effect of Nitric Oxide on the Expression of Matrix Metalloproteinase and Its Association with Migration of Cultured Trabecular Meshwork Cells // Korean J. Ophthalmol. – 2016. – Vol. 30, № 1. – P. 66-75.

Klein A. B., Williamson R., Santini M. A., Clemmensen C., Ettrup A., Rios M., et al. (2011). Blood BDNF Concentrations Reflect Brain-Tissue BDNF Levels across Species. Int. J. Neuropsychopharmacol. 14 (3), 347–353.

Ko M.L., Hu D.N., Ritch R., Sharma S.C., Chen C.F. Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats // Neurosci Lett. – 2001. – Vol.305. – N 2. – P.139-142.

Kolb H., Nelson R., Ahnelt P., Cuenca N. Cellular organization of the vertebrate retina // Concept and Challenges in Retinal Biology / Kolb H., Ripps H., Wu S. (eds.). Elsevier, 2004. Chapter 1. P. 3–26.

Lambert W.S., Clark A.F., Wordinger R.J. Effect of exogenous neurotrophins on Trk receptor phosphorylation, cell proliferation, and neurotrophin secretion by cells isolated from the human lamina cribrosa // Mol Vis. – 2004. – Vol 19. – N 10. – P.289-296.

Lambuk L, Mohd Lazaldin MA, Ahmad S, Iezhitsa I, Agarwal R, Uskoković V, Mohamud R. Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art. Front Pharmacol. 2022 May 20; 13:875662. doi: 10.3389/fphar.2022.875662. PMID: 35668928; PMCID: PMC9163364.

Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H., Barde Y.A. Molecular cloning and expression of brain-derived neurotrophic factor // Nature. – 1989. Vol. 341. – P. 149-152.

Levi‐Montalcini R., Hamburger V. (1951). Selective Growth Stimulating Effects of Mouse Sarcoma on the Sensory and Sympathetic Nervous System of the Chick Embryo. J. Exp. Zoology 116 (2), 321–361

Li H.Y., Zhao J.L., Zhang H. Transfection of brain-derived neurotrophic factor gene by recombinant adeno-associated virus vector in retinal ganglion cells in vitro // Zhonghua Yan Ke Za Zhi. – 2008. – Vol. 44. – N 4. – P.354-360.

Lu B., Pang P. T., Woo N. H. (2005). The Yin and Yang of Neurotrophin Action. Nat. Rev. Neurosci. 6 (8), 603–614.

Lucas R.J. Mammalian inner retinal photoreception // Curr. Biology. 2013. Vol. 23. P. 125–133.

Lusthaus J., Goldberg I. (2019). Current Management of Glaucoma. Med. J. Aust. 210 (4), 180–187.

Martin K.R., Quigley H.A. Gene therapy for optic nerve disease // Eye (Lond). – 2004. – Vol.18. – N 11. – P.1049-1055.

Martinowich K., Manji H., Lu B. New insights into BDNF function in depression and anxiety // Nat. Neurosci. – 2007. – Vol. 10. – P. 1089-1093.],

Matveeva N.Y., Kalinichenko S.G., Edranov S.S. Morphofunctional characteristics of retinal ganglion cells and their condition in open-angle glaucoma. Pacific Medical Journal, 2015, No. 3, p. 6–10.

Mojtabavi H., Saghazadeh A., van den Heuvel L., Bucker J., Rezaei N. (2020). Peripheral Blood Levels of Brain-Derived Neurotrophic Factor in Patients with Post-traumatic Stress Disorder (PTSD): A Systematic Review and Meta-Analysis. PLoS One 15 (11), e0241928.

Narzullaeva DU, Latipova NKh, Bobokha LYu(2024). Importance of parental compliance in postoperative rehabilitation of children with glaucoma. Bulletin of Ophthalmology 138(4): 11–15. (In Russ.). https://doi.org/10.17116/oftalma20241380

Narzullaeva DU (2024). The significance of the biomarker of glaucoma in children. Bulletin of the Tashkent Medical Academy №9.150-152

Pease M.E., McKinnon S.J., Quigley H.A., Kerrigan-Baumrind L.A., Zack D.J. (2000) Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma // Invest Ophthalmol Vis Sci. Vol. 41. – N 3. – P.764-774.

Reichardt L. F. (2006). Neurotrophin-regulated Signalling Pathways. Philos. Trans. R. Soc. Lond B Biol. Sci. 361 (1473), 1545–1564.

Shpak A. A., Guekht A. B., Druzhkova T. A., Kozlova K. I., Gulyaeva N. V. (2018). Brain-derived Neurotrophic Factor in Patients with Primary Open-Angle Glaucoma and Age-Related Cataract. Curr. Eye Res. 43 (2), 224–231.

Smith C. A., West M. E., Sharpe G. P., Hutchison D. M., Shuba L. M., Rafuse P. E., et al. (2020). Asymmetry Analysis of Macular Optical Coherence Tomography Angiography in Patients with Glaucoma and Healthy Subjects. Br. J. Ophthalmol. 104 (12), 1724–1729

Ster A.M., Popp R.A., Petrisor F.M. et al. The Role of Oxidative Stress and Vascular Insufficiency in Primary Open Angle Glaucoma // Clujul Medical. – 2014. – Vol. 87, № 3. – P. 143-146.

Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and conseguences // Prog. Retin. Eye Res. – 2006. – Vol. 25. – P. 490-513

Trick G.L., Trick L.R., Morris P., Wolf M. Visual field loss in senile dementia of the Alzheimer`s disease type // Neurology. – 1995. – Vol. 45. – P. 68-74

Tsai J. C. (2020). Innovative IOP-independent Neuroprotection and Neuroregeneration Strategies in the Pipeline for Glaucoma. J. Ophthalmol. 2020, 9329310.

Volbracht C1, van Beek J, Zhu C, Blomgren K, Leist M. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity // Eur J Neurosci. – 2006. – Vol. 23. – N 10. – P. 2611-2622.

Weinreb R. N., Liebmann J. M., Cioffi G. A., Goldberg I., Brandt J. D., Johnson C. A., et al. (2018). Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies. Ophthalmology 125 (12), 1874–1885